Fundraising Fox
Ilumivu
Fairview, US · Founded 2021 · Delaware corporation · 3 known investors
Find your way into Ilumivu
203 people in our graph can introduce you to the Ilumivu team.
Sign up to see every warm intro you have to Ilumivu
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ilumivu team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology. The company originated in support of families of children with autism and works with researchers, clinicians, and healthcare organizations.
Founders & leadership
Ilumivu was founded in 2021 by Mark Tuomenoksa.
MT
Mark TuomenoksaCo-Founder & Chief Technology OfficerHe founded OpenReach in 1999 and led it as CEO until its merger into Oracle in 2003, and has owned and run Tefsoft Inc since 2003. His earlier work includes consulting for CTC Communications and One Communications, a board seat at Network-1 Security Solutions, and a software engineering and marketing role at Angel Medical Systems.
KR
Kate RahimzadehChief Operating OfficerKate Rahimzadeh is a registered nurse with experience in healthcare operations, clinical research, regulatory affairs, and medical devices. She has held leadership roles overseeing healthcare teams and investigations into fraud and waste, and currently serves as Chief Operating Officer of Ilumivu.
SG
Sandeep GoelNamed on SEC filing
Investors · 3
Homebrewlisted by HomebrewBurlingame · $100K – $500K
How we know: Homebrew's portfolio page · Not right? Tell us
Hatteras Venture PartnersreportedResearch Triangle · $500K – $4Mvia Lauren Pierce Flickinger · board
How we know: board seat on SEC Form D · the VCSheet dataset · Not right? Tell us
Health Catalyst CapitalreportedNew York
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$256.2K disclosed across 1 of 4 rounds · 2021–2023
▶$256.2KraisedNov 2023 · 2 investors · Other TechnologyRule 506(b)
▶$256.2KraisedNov 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric ReifsniderExecutive Officer
- James Bradley WilsonDirector
- Kevin McCarthyDirector
- Marc Frank JacksonDirector
- Sandeep GoelExecutive Officer, Director, Promoter
- Daniel RossDirector
- Susan SteinmanExecutive Officer
- Michael HelmekeExecutive Officer
- Lauren Pierce FlickingerDirector
- Offering amount
- $1.5M
- Amount sold
- $256.2K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.5MofferedJan 2023 · Other TechnologyRule 506(b)
▶$1.5MofferedJan 2023 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sandeep GoelExecutive Officer, Director, Promoter
- Kevin McCarthyDirector
- Thomas David SmithExecutive Officer, Director, Promoter
- Lauren Pierce FlickingerDirector
- Dan RossDirector
- Offering amount
- $1.5M
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MofferedApr 2022 · Other TechnologyRule 506(b)
▶$2.5MofferedApr 2022 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dan RossDirector
- Thomas David SmithExecutive Officer, Director, Promoter
- Kevin McCarthyDirector
- Sandeep GoelExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Minimum investment
- $100K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$10.6MofferedOct 2021 · Other TechnologyRule 506(b)
▶$10.6MofferedOct 2021 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sandeep GoelExecutive Officer, Director, Promoter
- Offering amount
- $10.6M
- Minimum investment
- $10K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
ExpiWellExpiWell provides ecological momentary assessment (EMA) and experience sampling (ESM) software used by researchers to capture real-time data on participants' daily experiences, emotions, and behaviors. The platform enables peer-reviewed research across psychology, medicine, organizational behavior, and ESM methodology.
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
Companies working in the same space as Ilumivu.
In the news
Frequently asked questions
- What does Ilumivu do?
- ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology. The company originated in support of families of children with autism and works with researchers, clinicians, and healthcare organizations.
- Who founded Ilumivu?
- Ilumivu was founded by Mark Tuomenoksa in 2021.
- Who are Ilumivu's investors?
- Ilumivu's investors include Homebrew, Hatteras Venture Partners, Health Catalyst Capital.
- How much funding has Ilumivu raised?
- Ilumivu has disclosed $256.2K raised across 1 of its 4 known rounds.
- Where is Ilumivu headquartered?
- Ilumivu is headquartered in Fairview, US.